Completed

A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

J2W-MC-PYAA - ClinicalTrials.gov - NCT04411628

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate it.
How long will I be in the trial?
Participation could last about 8 weeks and may include up to 15 visits in the hospital or in the home.
Email
Completed

A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

J2W-MC-PYAA - ClinicalTrials.gov - NCT04411628

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate it.
How long will I be in the trial?
Participation could last about 8 weeks and may include up to 15 visits in the hospital or in the home.
Email

Key Requirements

Age :

18-75

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-75

Sex

All

Participants must

Participants must have at least moderate COVID-19 illness

Participants must have at least one of the following: fever, cough, sore throat, loss of taste or smell, weakness, headache, muscle pain, shortness of breath, or difficulty breathing

Participants must be in the hospital

Participants must NOT

Participants must not be on a ventilator (a type of machine that helps people breathe when they are very sick)

Participants must not be residents in nursing homes or long-term care centers before coming to the hospital

Participants must not have a serious medical condition or infection other than COVID-19

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

COVID-19 (Coronavirus)

What the trial is testing?

LY3819253, LY-CoV555

Could I receive a Placebo?

yes

Enrollment Goal

40

Trial Dates

March 2020 - August 2020

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-75

Sex

All

Participants must

Participants must have at least moderate COVID-19 illness

Participants must have at least one of the following: fever, cough, sore throat, loss of taste or smell, weakness, headache, muscle pain, shortness of breath, or difficulty breathing

Participants must be in the hospital

Participants must NOT

Participants must not be on a ventilator (a type of machine that helps people breathe when they are very sick)

Participants must not be residents in nursing homes or long-term care centers before coming to the hospital

Participants must not have a serious medical condition or infection other than COVID-19

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

COVID-19 (Coronavirus)

What the trial is testing?

LY3819253, LY-CoV555

Could I receive a Placebo?

yes

Enrollment Goal

40

Trial Dates

March 2020 - August 2020

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

COVID-19 (Coronavirus) Resources

COVID-19

Lilly's COVID-19 Clinical Trials are Underway

Lilly has worked quickly to launch studies of potential COVID-19 antibody treatments. Find out what makes antibodies an intriguing scientific and medical option.
COVID-19

Types of Clinical Research for COVID-19

As the world works to quickly learn about COVID-19, a mix of research studies is underway. This guide explains the different types of COVID-19 studies and what researchers hope to learn from them.
COVID-19 teams chat

COVID-19 Research

COVID-19 is caused by SARS-CoV-2, a novel coronavirus. Because it is a relatively new disease, scientists and physicians do not know much about it, and currently, there are not many medicines to treat it. That’s why we need clinical research—to test potential new treatments for COVID-19. Read on to see if a clinical trial may be right for you.
Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?